Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Nuvalent Inc | 5,363,379 | 5,269,433 | -93,946 | $419.85M | $373.71M | 17.20% | -$46.14M |
| Arcellx Inc COMMON STOCK | 4,371,601 | 4,492,032 | +120,431 | $335.26M | $294.68M | 13.56% | -$40.58M |
| Revolution Medicines, Inc.(RVMD) | 6,553,111 | 6,178,111 | -375,000 | $286.63M | $218.46M | 10.06% | -$68.18M |
| BeOne Medicines AGADS(ONC) | 616,024 | 666,024 | +50,000 | $113.79M | $181.27M | 8.34% | +$67.49M |
| Merus N V | 1,689,922 | 3,369,699 | +1,679,777 | $71.06M | $141.83M | 6.53% | +$70.77M |
| Tarsus Pharmaceuticals, Inc.(TARS) | 2,531,896 | 2,610,197 | +78,301 | $140.19M | $134.09M | 6.17% | -$6.11M |
| Edgewise Therapeutics, Inc.(EWTX) | 4,493,929 | 4,394,556 | -99,373 | $119.99M | $96.68M | 4.45% | -$23.31M |
| Janux Therapeutics, Inc.(JANX) | 3,515,986 | 3,329,909 | -186,077 | $188.25M | $89.91M | 4.14% | -$98.34M |
| Crinetics Pharmaceuticals In | 1,910,761 | 1,946,168 | +35,407 | $97.70M | $65.27M | 3.00% | -$32.42M |
| Vaxcyte, Inc.(PCVX) | 1,422,787 | 1,696,481 | +273,694 | $116.47M | $64.06M | 2.95% | -$52.41M |
| Disc Medicine, Inc.(IRON) | 1,497,720 | 1,210,971 | -286,749 | $94.96M | $60.11M | 2.77% | -$34.84M |
| Cogent Biosciences, Inc.(COGT) | 4,917,412 | 8,963,655 | +4,046,243 | $38.36M | $53.69M | 2.47% | +$15.34M |
| LENZ Therapeutics, Inc.(LENZ) | 770,455 | 1,511,932 | +741,477 | $22.24M | $38.87M | 1.79% | +$16.63M |
| Apogee Therapeutics Inc | 1,283,766 | 961,707 | -322,059 | $58.15M | $35.93M | 1.65% | -$22.23M |
| argenx SEADR(ARGX) | 481,305 | 59,679 | -421,626 | $296.00M | $35.32M | 1.63% | -$260.68M |
| Cytokinetics, Incorporated(CYTK) | 0 | 858,664 | +858,664 | $0 | $34.51M | 1.59% | +$34.51M |
| Insmed Incorporated(INSM) | 0 | 451,359 | +451,359 | $0 | $34.43M | 1.59% | +$34.43M |
| Spyre Therapeutics, Inc.(SYRE) | 1,527,205 | 2,127,205 | +600,000 | $35.55M | $34.32M | 1.58% | -$1.23M |
| Metsera Inc | 0 | 1,191,462 | +1,191,462 | $0 | $32.43M | 1.49% | +$32.43M |
| Viridian Therapeutics, Inc.(VRDN) | 1,820,079 | 2,095,079 | +275,000 | $34.89M | $28.24M | 1.30% | -$6.65M |
| Olema Pharmaceuticals, Inc.(OLMA) | 7,304,970 | 6,741,172 | -563,798 | $42.59M | $25.35M | 1.17% | -$17.24M |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 1,772,211 | 627,423 | -1,144,788 | $95.97M | $24.51M | 1.13% | -$71.45M |
| Arcutis Biotherapeutics, Inc.(ARQT) | 0 | 1,465,334 | +1,465,334 | $0 | $22.92M | 1.05% | +$22.92M |
| Y-Mabs Therapeutics Inc | 4,236,346 | 4,236,346 | 0 | $33.17M | $18.77M | 0.86% | -$14.40M |
| Erasca, Inc.(ERAS) | 10,752,354 | 10,802,354 | +50,000 | $26.99M | $14.80M | 0.68% | -$12.19M |
| Ocular Therapeutix, Inc.(OCUL) | 0 | 1,314,018 | +1,314,018 | $0 | $9.63M | 0.44% | +$9.63M |
| Immatics N.V.SHS(IMTX) | 5,414,409 | 1,907,108 | -3,507,301 | $38.50M | $8.60M | 0.40% | -$29.90M |
| Agios Pharmaceuticals, Inc.(AGIO) | 276,439 | 0 | -276,439 | $9.08M | $0 | — | -$9.08M |
| Oruka Therapeutics, Inc.(ORKA) | 819,660 | 0 | -819,660 | $15.89M | $0 | — | -$15.89M |
| Pliant Therapeutics, Inc.(PLRX) | 3,197,050 | 0 | -3,197,050 | $42.11M | $0 | — | -$42.11M |
| Scholar Rock Holding Corporation(SRRK) | 400,000 | 0 | -400,000 | $17.29M | $0 | — | -$17.29M |
| Tectonic Therapeutic, Inc.(TECX) | 485,105 | 0 | -485,105 | $22.40M | $0 | — | -$22.40M |
| Vera Therapeutics, Inc.CL A(VERA) | 1,437,339 | 0 | -1,437,339 | $60.79M | $0 | — | -$60.79M |